Posts for Ticker ‘AFFX’

Top Day Trader Alerts (BIDU, GOOG, NBG, MRNA, TQNT, AFFX)

These are today’s top day trader and active trader alerts seen with large price and volume moves in the pre-market.  We have more details on analysis and data on a link to VSInvestor.com for each story stock:

Baidu. Inc. (NASDAQ:BIDU) is soaring by double-digits on hope that Google will really leave China.

Google Inc. (NASDAQ: GOOG) is down about 2% on its China news.

National Bank of Greece SA (NYSE: NBG) is the stock of Greece to watch for the EU accusations that Greece falsified financial data that is far worse than the 12.5% budget deficit.

MDRNA, Inc. (NASDAQ: MRNA) is flying up 78% on already exponential trading volume on positive cancer data.

TriQuint Semiconductor, Inc. (NASDAQ: TQNT) is up almost 4% on guidance.

Affymetrix Inc. (NASDAQ: AFFX) is down 14% on a downgrade.

You are invited to join our free daily email distribution list from 24/7 Wall St. to hear about ongoing day trader and options trader alerts, analyst upgrades and downgrades, stock and market rumors, Buffett and guru investor news, M&A and IPOs, and more.

JON C. OGG

Posted on: January 13, 2010 – 8:42 am in Pre-Market Activity, Trading Alert, , , , , ,

Top Pre-Market Analyst Downgrades (AFFX, APD, ACAS, AMLN, AMAT, AINV, CTXS, DRYS, XOM, IRBT, LRCX, NFLX, NSR, NHY, NYX, BTU, UPS)

Burning_money_picThese are some of the top pre-market analyst downgrades and cautious calls we are seeing this Thursday morning:

  • Affymetrix (AFFX) Cut to Underweight at JPMorgan.
  • Air Products (APD) Cut to Neutral at JPMorgan.
  • American Capital (ACAS) Cut to Underperform at KBW.
  • Amylin Pharma (AMLN) Cut to Sell at Canaccord.
  • Applied Materials (AMAT) Started as Sell with $8 target at Auriga.
  • Apollo Investment (AINV) Cut to Market Perform at KBW.
  • Citrix Systems (CTXS) Cut to Neutral at Credit Suisse.
  • DryShips (DRYS) Cut to Underperform at Oppenheimer.
  • Exxon Mobil (XOM) Cut to Neutral at Goldman Sachs.
  • iRobot (IRBT) Cut to Neutral at JPMorgan.
  • Lam Research (LRCX) Cut to Underperform at Credit Suisse.
  • Netflix (NFLX) Started as Sell at Maxim Group.
  • Neustar (NSR) Cut to Neutral at JPMorgan.
  • Norsk Hydro (NHY) Cut to Market Perform at Bernstein.
  • NYSE Euronext (NYX) Cut to Neutral at Piper Jaffray.
  • Peabody Energy (BTU) Cut to Market Perform at FBR.
  • United Parcel Service (UPS) Cut to Underweight at Morgan Stanley.

Jon C. Ogg
January 29, 2009

Posted on: January 29, 2009 – 7:57 am in Analyst Calls, , , , , , , , , , , , , , , , ,

The 52-Week Low Club (AFFX)(PIR)(AXL)

Sad_clownAmerican Axle (AXL) S&P downgrade due to big customer GM (GM) cutting production. Drops to $2.61 from 52-week high of $28.11.

Pier 1 (PIR) Analyst dowgrade due to weak same-store sales. Down to $1.58 from 52-week high of $8.25.

Affymetrix (AFFX) Misses Q3 sales forecasts. Sells off to $3.88 from 52-week high of $28.12.

Douglas A. McIntyre

Posted on: October 13, 2008 – 2:43 pm in HI/LOW, ,

Earnings Confessions Starting (AFFX, BEAV, COHR, CONN, NTY, ORBK)

BurningmoneyAs we are entering earnings season, we are also starting to get "confession season" where companies begin issuing updates ahead of their formal earnings.  Some of these will make some obvious sense, and others are almost counter-intuitive. Here is a look at some recent annooucements.

Read More »

Posted on: October 13, 2008 – 8:06 am in Earnings Warning, , , , , ,

Top Pre-Market Analyst Downgrades (AFFX, CLNE, MER, NTRS, SPLS, TU)

These are some of the top downgrades or cautious calls we are seeing from analysts this Friday morning:

  • Affymetrix (AFFX) Started as Underweight at Morgan Stanley.
  • Clean Energy (CLNE) Cut to Underperform at National Bank.
  • Merrill Lynch (MER) Cut to Sell at Goldman Sachs.
  • Northern Trust (NTRS) Cut to Sell at Sandler O’Neill.
  • Staples (SPLS) Started as Underperform at FBR.
  • Telus Corp. (TU) Cut to Neutral at UBS.

Jon C. Ogg
September 5, 2008

Posted on: September 5, 2008 – 6:57 am in Analyst Calls, , , , , ,

The 52-Week Low Club 7/25/2008 (SSP)(MNI)(CVG)(ATI)(CROX)(AFFX)

Sad_clownScripps (SSP) Newspaper stock takes big hit on earnings. Falls to $7.17 from 52-week high of $147.78.

McClatchy Newspapers (MNI) Another newspaper company with problems. Sells down to $4.30 from 52-week high of $26.43.

Convergys (CVG) Still dropping after downgrade, to $11.77 against 52-week high of $20.

Read More »

Posted on: July 25, 2008 – 3:49 pm in HI/LOW, , , , , ,

The 52-Week Low Club (BORL)(SIGM)(NVTL)(AFFX)(CROX)

Fremont General  (FMT) Down 50% today. Finally delisted. Hit bottom at $.26 against 52-week high of $13.80.

Avnet (AVT) Warns on profits. Slips to $27.76 from 52-week high of $44.68.

Kinetic Concepts (KCI) Sells convertible notes to fund acquisition. Drops to $40.27 from 52-week high of $66.77.

Northrop Grumman (NOC) Company plans to take first quarter charge. Sells down to $71.39 from 52-week high of $85.21.

Tesoro Corporation (TSO) Bad day for oil refiners. Concerns about margins. Falls to $25.06 from 52-week high of $65.98.

Gannett (GCI) Part of bath newspaper companies are taking. Sells off to $27.26 from 52-week high of $61.68.

Crocs (NASDAQ:CROX) Warns on numbers. Falls to $10.10 from 52-week high of $75.21.

Affymetrix (AFFX) Revised forecast for 2008 down. Drops to $10.08 from 52-week high of $31.95.

Novatel Wireless (NVTL) Company says it will miss Q1 numbers. Sells off to $7.42 from 52-week high of $29.14.

Sigma Designs (SIGM) Analyst says company is losing market share. Drops to $15.31 from 52-week high of $73.

Borland Software (BORL) No news. Project management software company shares move down to $1.40 from 52-week high of $6.22.

Douglas A. McIntyre

Posted on: April 15, 2008 – 3:00 pm in HI/LOW, , , , , , , , , , ,

Earnings Damage Widens Across Industries (CROX)(AFFX)(NVTL)

The latest earnings news is a clear and definite indicator that the earnings damage from the current slowdown is unlike to take prisoner.

Crocs (NASDAQ: CROX), the maker of odd-balls shoes and a former Wall St. darling, is off 37% on a weak first quarter forecast. The company blamed the weak retail environment, which has been showing up in same-store sales for several months. CROX trades at $11.05 now, down from a 52-week high of $75.21. Retail was already dead, but this gave some further confirmation.

Affymetrix (NASDAQ: AFFX), a leader in the technology of genetic analysis, cut its revenue forecast for the year to a range of $510 million to $490 million from a previous range of $505 million to $525 million. It said the drop was due to cut-backs in R&D spending at customers. Shares moved down to $10.76 from a 52-week high of $31.95. The stock is off 34% today.

In the tech and telecom sector wireless modem maker Novatel (NASDAQ: NVTL) cut is Q1 guidance and put in a new CEO. Sales are expected to be $91 million down from previous forecasts of $110 million.:The company said a product delay in Europe hurt its numbers. The stock dropped 20% and trades at $8.05 down from a 52-week high of $29.14.

Three unrelated companies in unrelated sectors.

Douglas A. McIntyre

Posted on: April 15, 2008 – 8:57 am in Earnings Warning, , ,

Top 10 Pre-Market Analyst Calls (AFFX, C, DIS, DSCM, GSIC, JBLU, PNRA, UN, UNTD, DVN, KWK, NFX, EOG, FTO)

These are not the only important analyst calls out there, but these are the top analyst calls that 24/7 Wall St. is focusing on:

  • Affymetric (AFFX) raised to Buy at UBS.
  • Citigroup (C) saw its Debt rating cut from Aa2 to Aa3 and financial strength cut from A to B at Moody’s based on capital ratios.
  • Disney (DIS) raised to Buy at UBS.
  • Drugstore.com (DSCM) started as Buy at Banc of America.
  • GSI Commerce (GSIC) cut to Hold at Jefferies.
  • Jetblue Airways (JBLU) raised to Peer Perform at Bear Stearns.
  • Panera Bread (PNRA) Cut to Neutral at Sun Trust Robinson Humphreys.
  • Unilever (UN) started as Buy at Banc of America.
  • United Online (UNTD) raised to Buy at Jefferies.
  • Credit Suisse makes downgrades in oil patch: Devon (DVN), EOG Resources (EOG), Frontier (FTO), Newfield Exploration (NFX), Quicksilver (KWK).

Jon C. Ogg
December 14, 2007

Posted on: December 14, 2007 – 8:19 am in Analyst Calls, , , , , , , , , , , , , ,

Affymetrix Year-Lows On Debt..No Good Deed Goes Unpunished (AFFX)

Affymetrix (NASDAQ:AFFX) was a bit of a puzzling stock today when we saw it had hit a 52-week low after a proposed $250 million convertible note offering.  After the near-10% haircut, this has a $1.5 Billion market cap, and its triple-digit P/E ratio is a bit misleading when you you consider the $0.30 2007 estimate and the $0.51 estimate for 2008.  Revenue estimates for 2007 and 2008 ar $371.7 million and $401.2 million, respectively.

The company isn’t without troubles, because it will lose some key Roche revenues in 2008 and it has increased its patent lawsuits against Illumina.

Its recently established diagnostics business is the hopeful here, but  its partners need FDA marketing approval before that becomes a huge win.

As of September 30, its current assets were $400 million, and total assets outside of Goodwill, deferrals, and ‘other’ are in the vicinty of $600 million.  Its current liabilities are $79+ million and other longer-term debt (including another convertible note) total just under $137 million more; so total liabilities are about $216 million.

The 30-year $250 million in notes may even be used to retire a portion of its previously issued notes.  The terms and conditions will be negotiated between Affymetrix and J.P.Morgan, its underwriter.  The "use of proceeds" from this offering is for general corporate purposes.  This near-10% drop to $21.72 is a loss of of one-third its value from highs as the 52-week trading range $21.58 to $31.95.  Defending triple digit P/E stocks on announcements isn’t what 24/7 Wall St.normally does.  But in this case the financing pact may be deemed cheap.

We’ll evaluate the full spectrum of analyst comments tonight and tomorrow and after we get word of the terms and conditions of the financing, but this sell-off seems excessive for a stock that traded up to $28 last month before its quarterly report.

Jon C. Ogg
November 13, 2007

Jon Ogg produces the 24/7 Wall St. Special Situation Investing Newsletter; he does not own securities in the companies he covers.

Posted on: November 13, 2007 – 4:03 pm in Biotech, Medical, Secondary Offering,